2022年7月5日,中国证监会(以下简称“监证会”)发布消息称,证监会收到上海证券交易报送的关于南京麦澜德医疗科技股份有限公司(以下简称“麦澜德”)首次公开发行股票并在科创板上市的审核意见及注册申请文件。经审阅上海证券交易所审核意见及公司注册申请文件,证监会同意麦澜德首次公开发行股票的注册申请。
![](https://www.innomd.org/img/article/fa97718483cf46299439144c6648108f.png)
|
|
|
|
||
|
|
|
|
![]() |
|
|
![]() |
|
|||
|
|
|
![]() |
|
|
|
![]() |
|
|||
|
|
|
![]() |
|
|
|
|
|
![]() |
|
|
|
![]() |
|
|||
|
![]() |
|
|||
![](https://www.innomd.org/img/article/506059c665bb43f480ff0aae21f1246c.png)
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2022年7月5日,中国证监会(以下简称“监证会”)发布消息称,证监会收到上海证券交易报送的关于南京麦澜德医疗科技股份有限公司(以下简称“麦澜德”)首次公开发行股票并在科创板上市的审核意见及注册申请文件。经审阅上海证券交易所审核意见及公司注册申请文件,证监会同意麦澜德首次公开发行股票的注册申请。
|
|
|
|
||
|
|
|
|
![]() |
|
|
![]() |
|
|||
|
|
|
![]() |
|
|
|
![]() |
|
|||
|
|
|
![]() |
|
|
|
|
|
![]() |
|
|
|
![]() |
|
|||
|
![]() |
|
|||
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|